Cerebral involvement in McLeod syndrome: The first autopsy revisited

Neuroacanthocytosis Syndromes II

Volumn , Issue , 2008, Pages 205-215

  Danek, A ^a   Neumann, M ^a   Brin, M F ^b   Symmans, W A ^c   Hays, A P ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Hamilton Regional Laboratory Medicine Program   (New Zealand)

^d Department of Orthopaedic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052963597     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-71693-8_17     Document Type: Chapter

References (49)

1. Allen FH, Krabbe S M R, Corcoran PA (1961) A new phenotype (McLeod) in the Kell bloodgroup system. Vox Sang 6:555-560
2. Alonso ME, Teixeira F, Jimenez G et al. (1989) Chorea-acanthocytosis: report of a family and neuropathological study of two cases. Can J Neurol Sci 16:426-431
3. Arzberger T, Heinsen H, Buresch N et al. (2006) The neuropathology of chorea-acanthocytosis: from stereology to an immunohistochemical detection of chorein. Mov Disord 20:1679
4. Bader B (2007) Neuropathology of chorea-acanthocytosis. Mov Disord 22:VI
5. Bader B, Arzberger T, Dobson-Stone C et al. (2007) Detection of chorein in postmortem brain tissue of chorea-acanthocytosis patients and nonaffected controls by Western blot. Mov Disord 22:VI
6. Bertelson CJ, Pogo AO, Chaudhuri A et al. (1988) Localization of the McLeod locus (XK) within Xp21 by deletion analysis. Am J Hum Genet 42:703-711
7. Bird TD, Cederbaum S, Valpey RW et al. (1978) Familial degeneration of the basal ganglia with acanthocytosis: a clinical, neuropathological, and neurochemical study. Ann Neurol 3:253-258
8. Brin MF (1993) Acanthocytosis. In: Goetz CG, Tanner CM, Aminoff MJ (eds) Handbook of clinical neurology, vol 19(63): Systemic diseases, Part I. Elsevier, Amsterdam, pp 271-299
9. Brin MF, Hays A, Symmans WA et al. (1993) Neuropathology of McLeod phenotype is like choreaacanthocytosis (CA). Can J Neurol Sci 20(Suppl):S234
10. Burbaud P, Vital A, Rougier A et al. (2002) Minimal tissue damage after stimulation of the motor thalamus in a case of chorea-acanthocytosis. Neurology 59:1982-1984
11. Claperon A, Hattab C, Armand V et al. (2007) The Kell and XK proteins of the Kell blood group are not co-expressed in the central nervous system. Brain Res 1147:12-24
12. Danek A (2004) Neuroacanthocytosis syndromes: what links red blood cells and neurons? In: Danek A (ed) Neuroacanthocytosis syndromes. Springer, Dordrecht, The Netherlands, pp 1-14
13. Danek A, Rubio JP, Rampoldi L et al. (2001) McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 50:755-764
14. Danek A, Uttner I, Vogl T et al. (1994) Cerebral involvement in McLeod syndrome. Neurology 44:117-120
15. De Yébenes JG, Brin MF, Mena MA et al. (1988) Neurochemical findings in neuroacanthocytosis. Mov Disord 3:300-312
16. De Yébenes JG, Vazquez A, Martínez A et al. (1988) Biochemical findings in symptomatic dystonias. Adv Neurol 50:167-175
17. Feinberg TE, Cianci CD, Morrow JS et al. (1991) Diagnostic tests for choreoacanthocytosis. Neurology 41:1000-1006
18. Galatioto S, Serra S, Batolo D et al. (1993) Amyotrophic choreo-acanthocytosis: a neuropathological and immunocytochemical study. Ital J Neurol Sci 14:49-54
19. Galey WR, Evan AP, Van Nice PS et al. (1978) Morphology and physiology of the McLeod erythrocyte. Vox Sang 34:152-161
20. Geser F, Prokop S, Glatzel M et al. (2007) The neuropathology of McLeod syndrome: a case study. Mov Disord 22:VI
21. Giblett ER, Klebanoff SJ, Pincus SH et al. (1971) Kell phenotypes in chronic granulomatous disease: a potential transfusion hazard. Lancet I:1235-1236
22. Hardie RJ, Pullon H W H, Harding AE et al. (1991) Neuroacanthocytosis: a clinical, haematological and pathological study of 19 cases. Brain 114:13-49
23. Henkel K, Danek A, Grafman J et al. (2006) Head of the caudate nucleus is most vulnerable in chorea-acanthocytosis: a voxel-based morphometry study. Mov Disord 21:1728-1731
24. Ho M, Chelly J, Carter N et al. (1994) Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 77:869-880
25. Ho MF, Chalmers RM, Davis MB et al. (1996) A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis. Ann Neurol 39:672-675
26. Ho MF, Monaco AP, Blonden L A J et al. (1992) Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21. Am J Hum Genet 50:317-330
27. Ishida C, Makifuchi T, Saiki S et al. (2007) An autopsied case of chorea-acanthocytosis with a single detected mutation of VPS13A. Mov Disord 22:VI
28. Iwata M, Fuse S, Sakuta M et al. (1984) Neuropathological study of chorea-acanthocytosis. Jpn J Med 23:118-122
29. Lee S, Lin M, Mele A et al. (1999) Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood 94:1440-1450
30. Lee S, Sha Q, Wu X et al. (2007) Expression profiles of mouse Kell, XK, and XPLAC mRNA. J Histochem Cytochem 55:365-374
31. Malandrini A, Fabrizi GM, Palmeri S et al. (1993) Choreo-acanthocytosis like phenotype without acanthocytes: clinicopathological case report. Acta Neuropathol (Berl) 86:651-658
32. Marsh NJ, Marsh WL, Johnson CL et al. (1980) Evidence of a muscular defect in subjects with McLeod syndrome. Transfusion 20:618-619
33. Marsh WL, Marsh NJ, Moore A et al. (1981) Elevated serum creatine phosphokinase in subjects with McLeod syndrome. Vox Sang 40:403-411
34. Marsh WL, Šyen R, Nichols ME et al. (1975) Chronic granulomatous disease and the Kell blood groups. Br J Haematol 29:247-262
35. Martinez A, Mena MA, Jamrozik Z et al. (2004) Pathology of neuroacanthocytosis and of Huntington's disease. In: Danek A (ed) Neuroacanthocytosis syndromes. Springer, Dordrecht, pp 87-94
36. Ochiai J, Takeuchi Y, Mabuchi C et al. (2007) A case of chorea-acanthocytosis: clinico-pathological presentation. Mov Disord 22:VI
37. Rafalowska J, Drac H, Jamrozik S (1996) Neuroacanthocytosis. Review of literature and case report. Folia Neuropathol 34:178-183
38. Rampoldi L, Dobson-Stone C, Rubio JP et al. (2001) A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet 28:119-120
39. Rinne JO, Daniel SE, Scaravilli F et al. (1994) Nigral degeneration in neuroacanthocytosis. Neurology 44:1629-1632
40. Rinne JO, Daniel SE, Scaravilli F et al. (1994) The neuropathological features of neuroacanthocytosis. Mov Disord 9:297-304
41. Sato Y, Ohnishi A, Tateishi J et al. (1984) An autopsy case of chorea-acanthocytosis. Special reference to the histopathological and biochemical findings of basal ganglia. Brain Nerve (Tokyo) 36:105-111
42. Schwartz SA, Marsh WL, Symmans A et al. (1982) 'New' clinical features of McLeod syndrome. Transfusion 22:404
43. Sobue G, Mukai E, Fujii K et al. (1986) Peripheral nerve involvement in familial chorea-acanthocytosis. J Neurol Sci 76:347-356
44. Spencer SE, Walker FO, Moore SA (1987) Chorea-amyotrophy with chronic hemolytic anemia: a variant of chorea-amyotrophy with acanthocytosis. Neurology 37:645-649
45. Symmans WA, Shepherd CS, Marsh WL et al. (1979) Hereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system. Br J Haematol 42:575-583
46. Ueno S-I, Maruki Y, Nakamura M et al. (2001) The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis. Nat Genet 28:121-122
47. Van Den Buuse M (2004) Endothelins as basal ganglia transmitters. In: Danek A (ed) Neuroacanthocytosis syndromes. Springer, Dordrecht, The Netherlands, pp 205-212
48. Vital A, Bouillot S, Burbaud P et al. (2002) Chorea-acanthocytosis: neuropathology of brain and peripheral nerve. Clin Neuropathol 21:77-81
49. Wimer BM, Marsh WL, Taswell HF et al. (1977) Haematological changes associated with the McLeod phenotype of the Kell blood group system. Br J Haematol 36:219-224